P2X7 receptors:: Properties and relevance to CNS function

被引:116
作者
Duan, Shumin [1 ]
Neary, Joseph T.
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China
[3] Univ Miami, Sch Med, Miami VA Med Ctr,Res Serv, Dept Pathol, Miami, FL 33152 USA
[4] Univ Miami, Sch Med, Miami VA Med Ctr,Res Serv, Dept Biochem, Miami, FL 33152 USA
[5] Univ Miami, Sch Med, Miami VA Med Ctr,Res Serv, Dept Mol Biol, Miami, FL 33152 USA
[6] Univ Miami, Sch Med, Neurosci Program, Miami, FL 33152 USA
关键词
P2X(7); neuron-glia interaction; transmitter release; ATP; glutamate;
D O I
10.1002/glia.20397
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Among seven members of P2X ionotropic receptors activated by extracellular ATP, the P2X(7) subtype is unique in that it can function as a cation channel, a nonselective pore, or even a signaling complex coupled with multiple downstream components. Several roles of P2X(7) receptors have been described in CNS cells in the past decade, including release of cytokines and transmitters, modulation of presynaptic transmitter release, and activation of multiple signaling pathways. The finding that P2X(7) pores may directly mediate efflux of cytosolic glutamate, GABA, and ATP in glial cells is particularly interesting, as it provides a novel mechanism of glial transmitter release that may play important roles not only in physiological intercellular communication but also in pathological neural injury. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:738 / 746
页数:9
相关论文
共 99 条
  • [1] ATP-induced ATP release from astrocytes
    Anderson, CM
    Bergher, JP
    Swanson, RA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 88 (01) : 246 - 256
  • [2] Phospholipases C and A2 control lysosome-mediated IL-1β secretion:: Implications for inflammatory processes
    Andrei, C
    Margiocco, P
    Poggi, A
    Lotti, LV
    Torrisi, MR
    Rubartelli, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9745 - 9750
  • [3] Armstrong JN, 2002, J NEUROSCI, V22, P5938
  • [4] Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS
    Atkinson, L
    Batten, TFC
    Moores, TS
    Varocqui, H
    Erickson, JD
    Deuchars, J
    [J]. NEUROSCIENCE, 2004, 123 (03) : 761 - 768
  • [5] A role for mitogen-activated protein kinaseErk1/2 activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death
    Auger, R
    Motta, I
    Benihoud, K
    Ojcius, DM
    Kanellopoulos, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (30) : 28142 - 28151
  • [6] P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes
    Ballerini, P
    Ciccarelli, R
    Caciagli, F
    Rathbone, MP
    Werstiuk, ES
    Traversa, U
    Buccella, S
    Giuliani, P
    Jiang, S
    Nargi, E
    Visini, D
    Santavenere, C
    Di Iorio, P
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (03) : 417 - 430
  • [7] Rat astroglial P2Z (P2X(7)) receptors regulate intracellular calcium and purine release
    Ballerini, P
    Rathbone, MP
    DiIorio, P
    Renzetti, A
    Giuliani, P
    DAlimonte, I
    Trubiani, O
    Caciagli, F
    Ciccarelli, R
    [J]. NEUROREPORT, 1996, 7 (15-17) : 2533 - 2537
  • [8] Agonists and antagonists acting at P2X7 receptor
    Baraldi, PG
    Di Virgilio, F
    Romagnoli, R
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (16) : 1707 - 1717
  • [9] Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor
    Baricordi, OR
    Melchiorri, L
    Adinolfi, E
    Falzoni, S
    Chiozzi, P
    Buell, G
    Di Virgilio, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) : 33206 - 33208
  • [10] Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms
    Beigi, RD
    Kertesy, SB
    Aquilina, G
    Dubyak, GR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) : 507 - 519